Ra Medical Systems Launches Pharos, Optimized Dermatology Excimer Laser. Credit: Business Wire.

Ra Medical Systems has launched Pharos, Optimized, a dermatology excimer laser for the treatment of patients with psoriasis, vitiligo, and atopic dermatitis.

The new device features an ergonomic handpiece to offer comfort for the operator and better visibility of the treatment site. Ra Medical said that Pharos is intended to improve both physician and patient experience.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The device also comes with adjustable aiming and laser beams in order to enable targeted treatments without affecting healthy tissue. Pharos’ small footprint makes it suitable for any type of treatment room.

Ra Medical Systems CEO Dean Irwin said: “The optimised Pharos is a next-generation laser that delivers what dermatologists have been asking for: faster treatments for psoriasis, vitiligo, and atopic dermatitis and an upgraded user and patient experience.”

According to the company, psoriasis, vitiligo, and atopic dermatitis impact a total of more than 25 million people living in the US. Pharos, Optimized is expected to offer a new treatment option for these conditions.

The new device has been initially displayed at the 2019 American Academy of Dermatology Summer Meeting held from 25 July to 28 July in New York, US.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Ra Medical develops excimer laser systems targeting vascular and dermatologic diseases. The company introduced Pharos in 2004 to treat dermatological conditions, including psoriasis, vitiligo, and atopic dermatitis.

The company launched DABRA later in 2017, providing an endovascular treatment for blockages caused by lower extremity vascular disease.

Both devices are powered by the company’s excimer laser technology platform, which generates 308nm light that is believed to produce a targeted immunosuppressive effect.

The company operates a 32,000ft² manufacturing facility in Carlsbad, California, US for making DABRA and Pharos excimer lasers and catheters.